Compile Data Set for Download or QSAR
maximum 50k data
Found 319 with Last Name = 'binder' and Initial = 'fp'
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652310(US20240059675, Example 13)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652310(US20240059675, Example 13)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652312(US20240059675, Example 15)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652312(US20240059675, Example 15)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652313(US20240059675, Example 16)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652318(US20240059675, Example 21)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652324(US20240059675, Example 26)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652324(US20240059675, Example 26)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652363(US20240059675, Example 32)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652363(US20240059675, Example 32)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652300(US20240059675, Example 4)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652305(US20240059675, Example 8)
Affinity DataIC50: <1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652305(US20240059675, Example 8)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652309(US20240059675, Example 12)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652309(US20240059675, Example 12)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652316(US20240059675, Example 19)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652326(US20240059675, Example 28)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652327(US20240059675, Example 29)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652328(US20240059675, Example 30)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652328(US20240059675, Example 30)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652330(US20240059675, Example 31)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652297(US20240059675, Example 1)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652298(US20240059675, Example 2)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652299(US20240059675, Example 3)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652299(US20240059675, Example 3)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652301(US20240059675, Example 5)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652303(US20240059675, Example 6)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652304(US20240059675, Example 7)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652318(US20240059675, Example 21)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652319(US20240059675, Example 22)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652325(US20240059675, Example 27)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652326(US20240059675, Example 28)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652327(US20240059675, Example 29)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652330(US20240059675, Example 31)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652313(US20240059675, Example 16)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652314(US20240059675, Example 17)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652297(US20240059675, Example 1)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652306(US20240059675, Example 9)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652307(US20240059675, Example 10)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652325(US20240059675, Example 27)
Affinity DataIC50:  5nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652320(US20240059675, Example 23)
Affinity DataIC50:  6nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily A member 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM593717(US11578080, Example 23)
Affinity DataIC50:  6nMAssay Description:At the assay day cells were washed 3× with assay puffer, 20 μL buffer remained in the wells after washing. 10 μL Ca6 kit (Cat. R8191 Molecu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily A member 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM593716(US11578080, Example 22)
Affinity DataIC50:  7nMAssay Description:At the assay day cells were washed 3× with assay puffer, 20 μL buffer remained in the wells after washing. 10 μL Ca6 kit (Cat. R8191 Molecu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652314(US20240059675, Example 17)
Affinity DataIC50:  8nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652315(US20240059675, Example 18)
Affinity DataIC50:  8nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652303(US20240059675, Example 6)
Affinity DataIC50:  8nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652307(US20240059675, Example 10)
Affinity DataIC50:  8nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily A member 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM524064(US11136336, Example 15)
Affinity DataIC50:  9nMAssay Description:At the assay day cells were washed 3× with assay puffer, 20 μL buffer remained in the wells after washing. 10 μL Ca6 kit (Cat.R8191 Molecul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652311(US20240059675, Example 14)
Affinity DataIC50:  10nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652316(US20240059675, Example 19)
Affinity DataIC50:  10nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
Displayed 1 to 50 (of 319 total ) | Next | Last >>
Jump to: